Molecular epidemiology of polioviruses

被引:118
作者
Kew, OM
Mulders, MN
Lipskaya, GY
daSilva, EE
Pallansch, MA
机构
[1] NATL INST PUBL HLTH & ENVIRONM PROTECT, VIROL LAB, 3720 BA BILTHOVEN, NETHERLANDS
[2] MOSCOW MV LOMONOSOV STATE UNIV, AN BELOZERSKY INST PHYS CHEM BIOL, MOSCOW, RUSSIA
[3] OSWALDO CRUZ FDN, RIO DE JANEIRO, BRAZIL
来源
SEMINARS IN VIROLOGY | 1995年 / 6卷 / 06期
关键词
polioviruses; molecular epidemiology; virus evolution; polio eradication;
D O I
10.1016/S1044-5773(05)80017-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A worldwide effort is underway to eradicate poliomyelitis by the year 2000. Surveillance for wild poliovirus circulation is crucial to this effort. The use of molecular epidemiologic methods has enhanced the precision and reliability of poliovirus surveillance. Because poliovirus genomes evolve rapidly (similar to 10(-2) nt substitutions/site/yr) during replication in humans, the potential resolving power of the molecular epidemiologic studies based upon nucleotide sequence comparisons is very high. Evolution among wild polioviruses occurs by both nucleotide substitution (primarily to synonymous codons) and recombination. Sequence comparisons of poliovirus isolates have revealed the existence of numerous genotypes endemic to different regions of the world. Sequence diversity within a genotype is reduced by epidemics (as one lineage predominates), as well as by intensive immunization (as lineages are eliminated). Molecular epidemiologic approaches have been widely used within the Poliomyelitis Eradication Initiative to: (1) determine the sources of imported viruses, (2) follow the pathways of virus transmission, (3) monitor the progress of control activities, (4) identify reservoirs sustaining virus transmission (5) develop molecular reagents for the rapid detection of wild polioviruses in clinical and environmental samples, and (6) provide critical evidence that poliovirus eradication has been achieved.
引用
收藏
页码:401 / 414
页数:14
相关论文
共 77 条
[1]  
AGOL VI, 1991, ADV VIRUS RES, V40, P103
[2]  
ANDRUS JK, 1992, B WORLD HEALTH ORGAN, V70, P591
[3]  
[Anonymous], 1992, Wkly Epidemiol Rec, V67, P336
[4]  
[Anonymous], 1995, WKLY EPIDEMIOL REC, V70, P97
[5]   THE NATURAL GENOMIC VARIABILITY OF POLIOVIRUS ANALYZED BY A RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM ASSAY [J].
BALANANT, J ;
GUILLOT, S ;
CANDREA, A ;
DELPEYROUX, F ;
CRAINIC, R .
VIROLOGY, 1991, 184 (02) :645-654
[6]   POLIOMYELITIS IN SPAIN, 1982-1984 - VIROLOGICAL AND EPIDEMIOLOGIC STUDIES [J].
BERNAL, A ;
GARCIASAIZ, A ;
LIACER, A ;
DEORY, F ;
TELLO, O ;
NAJERA, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (01) :69-76
[7]   INTERTYPIC GENOMIC REARRANGEMENTS OF POLIOVIRUS STRAINS IN VACCINEES [J].
CAMMACK, N ;
PHILLIPS, A ;
DUNN, G ;
PATEL, V ;
MINOR, PD .
VIROLOGY, 1988, 167 (02) :507-514
[8]   RNA SEQUENCE VARIANTS IN LIVE POLIOVIRUS VACCINE AND THEIR RELATION TO NEUROVIRULENCE [J].
CHUMAKOV, KM ;
NORWOOD, LP ;
PARKER, ML ;
DRAGUNSKY, EM ;
RAN, YX ;
LEVENBOOK, IS .
JOURNAL OF VIROLOGY, 1992, 66 (02) :966-970
[9]  
CIRNE MD, 1995, J INFECT DIS, V171, P1097, DOI 10.1093/infdis/171.5.1097
[10]   OLIGONUCLEOTIDE PROBES FOR THE SPECIFIC DETECTION OF THE WILD POLIOVIRUS TYPE-1 AND TYPE-3 ENDEMIC TO BRAZIL [J].
DASILVA, EE ;
PALLANSCH, MA ;
HOLLOWAY, BP ;
OLIVEIRA, MJC ;
SCHATZMAYR, HG ;
KEW, OM .
INTERVIROLOGY, 1991, 32 (03) :149-159